ImmuCell Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
ImmuCell Corporation (ICCC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $22.20 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2025-11-13
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $1.04K, a 90.12% decline from fiscal 2022.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $10.53K.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2014 was $1.00K, a 87.50% decline from fiscal 2013.
- ImmuCell Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2013 was $8.00K, a 68.00% decline from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|
| 2025-09-30 | $22.20K 10-Q · filed 2025-11-13 | |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $1.04K 10-K · filed 2025-03-28 | |
| 2022-12-31 | $10.53K 10-K · filed 2024-04-01 | |
| 2014-12-31 | $1.00K 10-K · filed 2015-03-26 | |
| 2013-12-31 | $8.00K 10-K · filed 2015-03-26 | |
| 2012-12-31 | $25.00K 10-K · filed 2015-03-26 | |
| 2011-12-31 | $49.00K 10-K · filed 2014-03-26 | |
| 2010-12-31 | $3.00K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |